Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Accuracy of Revised Cardiac Risk Index With HbA1C:Hemoglobin Ratio (HH Ratio)

NCT05066386 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT05066386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05066386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Accuracy of Revised Cardiac Risk Index With HbA1C:Hemoglobin Ratio (HH Ratio)
Lead sponsor
Singapore General Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2013
Completion date
August 1, 2021
Enrollment
20,099 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

perioperative medicine, risk stratification